Results 11 to 20 of about 4,448 (111)
Abstract Background Plasma biomarkers have demonstrated excellent performances in detecting AD/ADRD‐related brain pathology. However, their relationship with cognitive decline remains unclear. We examined this in a large memory clinic cohort with baseline plasma biomarkers and repeated cognitive assessments over approximately three decades.
Zeng X +25 more
europepmc +2 more sources
Plasma Biomarkers Modulate APOE4 Genotype Risk in Cognitive Decline: Insights from a Large Memory Clinic Cohort [PDF]
Abstract Background The apolipoprotein E (APOE) 4 genotype is a major genetic risk factor of late‐onset Alzheimer's disease (AD). We examined the link between APOE4 carriage, cognitive decline and AD plasma biomarkers in a large memory clinic cohort with annual assessments spanning up to three decades.
Zeng X +25 more
europepmc +2 more sources
High p‐Tau217 Levels Nullify Age‐related Cognitive Protection in Younger Older Adults [PDF]
Abstract Background Plasma p‐tau217 is pivotal for diagnosing Alzheimer's Disease (AD) and monitoring its progression, with high p‐tau217 levels associated with amyloid pathology and faster cognitive decline. While younger age is generally expected to provide protection against cognitive decline, the interaction between p‐tau217 levels and age on the ...
Choity L +25 more
europepmc +2 more sources
Diagnostic Performance of Plasma Phospho‐tau217 for Alzheimer's Disease in a Large Memory Clinic Cohort [PDF]
Abstract Background Phospho‐tau217 (p‐tau217) has emerged as a leading blood‐based biomarker for Alzheimer's disease (AD) and has been recommended by an Alzheimer's Association Workgroup as a biomarker for AD pathology. However, its translational performance in clinical settings remains to be explored.
Sehrawat A +25 more
europepmc +2 more sources
Exploring Racial Differences in the Association of Plasma Biomarkers and APOE4 Genotype in a Large Memory Clinic Cohort [PDF]
Abstract Background The APOE4 is a major genetic risk factor for Alzheimer's disease (AD) and has been shown to impact plasma AD biomarker levels. We utilized a large memory clinic cohort to assess potential differences in this association race.
Zeng X +25 more
europepmc +2 more sources
Alzheimer's disease plasma biomarkers are differentially affected by Type II Diabetes Mellitus based on those with Alzheimer's disease [PDF]
Abstract Background Type II Diabetes Mellitus (T2DM) remains one of the strongest comorbidities associated with the development of AD. Use of fluid‐based biomarker assays allows for quick, inexpensive, and accurate identification of those at high risk for developing AD or likely already have the disease.
Grizzanti J +26 more
europepmc +2 more sources
GARIMPO DO TUCANO: ANÁLISE AMBIENTAL DE UM GARIMPO ABANDONADO NO NORDESTE DE GOIÁS
A atividade garimpeira integra as atividades de mineração, contudo sua existência leva à ocorrência de impactos no ambiente, além de envolver a questão social de maneira mais evidente.
Luciana Gonçalves Tibiriçá +2 more
doaj +1 more source
Resumo Pênfigo compreende grupo de doenças bolhosas autoimunes que possuem tendência à progressão, com evolução ilimitada e crônica e com prognóstico potencialmente fatal. O tipo mais comum é o Pênfigo Foliáceo Endêmico (PFE), caracterizado pela presença
Olívia Maria de Paula Alves Bezerra +7 more
doaj +1 more source
Mercury bioaccumulation in fishes of a paddy field in Southern of Brazil
Aim: The aim of present study was to evaluate the Hg concentration in two species of fish (Astyanax sp and Corydoras paleatus) and its potential use as a biomonitor, in order to know if the use of pesticides and fertilizers in paddy can enhance the Hg ...
Vinicius Tavares Kütter +5 more
doaj +1 more source
El objetivo de este estudio fue investigar la resistencia al mercurio y los antibióticos, y la transferencia de resistencia al mercurio por plásmidos conjugativos en 55 cepas de Escherichia coli aisladas de aguas superficiales del litoral de Lima, Perú ...
Marcos Alejandro Sulca López +1 more
doaj +1 more source

